Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes.
Aviram A, Mei-Dan E, Cassir G, Figueiro-Filho E, Liauw J, Jain V, Bujold E, Melamed N; SOGC Clinical Obstetrics Committee (2025); Audibert F, Boucoiran I, Cohen E, Coolen J, Dionne MD, Filho EF, Gomes M, Hobson S, Lim K, Nash C, Niles K, Smith G, Walji S, Wilcock G, Wou K; SOGC Guideline Management Oversight Committee (2025); Basso M, Cook J, Francoeur D, Guthrie B, Harris K, Healey S, Jain V, Jim B, Kotaska A, Metcalfe A, McLeod NL, Murji A, Papillon-Smith J, Poliquin V, Potestio F, Smith A, Wilson RD.
Aviram A, et al. Among authors: nash c.
J Obstet Gynaecol Can. 2025 Jul 25:103060. doi: 10.1016/j.jogc.2025.103060. Online ahead of print.
J Obstet Gynaecol Can. 2025.
PMID: 40716516